Check out Motoharu Sano on Amazon Music. Stream ad-free or purchase CD's and MP3s now on Amazon. No Damage MOTOHARU SANO. Someday Sano, Motoharu. Someday Sano, Motoharu. 20th Anniversay Editio Sano, Motoharu. Message for Soul Boy Motoharu Sano. VISITORS:20TH ANNIVERS MOTOHARU SANO. Sun Studio Edition Sano, Motoharu.

.Pepine, C J2000-12-28The optimal management approach for patients with non-ST-segment elevation acute coronary syndromes continues to be an issue of debate. An ischemia-guided strategy appears to be effective as an alternative to either a very conservative 'wait-and-see' approach or a very aggressive routine revascularization approach. The need for another approach is supported by the lack of conclusive evidence-based results favoring an early routine invasive treatment strategy. In the Thrombolysis in Myocardial Infarction (TIMI) IIIB trial, there were no differences in the incidence of death or myocardial infarction (MI) between patients treated with an early invasive approach and those treated with a conservative approach to treatment. Significantly worse outcomes were shown in patients assigned to an early invasive strategy in the Veterans Affairs Non-Q-Wave Infarction Strategies in Hospital (VANQWISH) trial at 1-year follow-up (111 clinical events in the invasive group vs 85 in the conservative group; p = 0.05). Registry information, including that from the Organization to Assess Strategies for Ischemic Syndromes (OASIS), which included approximately 8,000 patients with unstable angina or suspected MI, has even suggested an excess hazard with a routine invasive approach.

Patients with non-ST-segment elevation MI observed in the Global Use of Strategies to Open Occluded Coronary Arteries in Acute Coronary Syndromes (GUSTO)-IIB and Platelet IIb/IIIa in Unstable Angina: Receptor Suppression Using Integrilin Therapy (PURSUIT) trials also fared better with an ischemia-guided strategy. Even the recent FRagmin and Fast Revascularization during InStability in Coronary artery disease (FRISC II) trial investigators had to be very selective relative to eliminating high- risk patients in the first week and treating with intense anti-ischemic therapy and 5-7 days of low-molecular-weight heparin therapy to show an advantage for assigned revascularization. A careful clinical evaluation with.Safari, Saeed; Baratloo, Alireza; Hashemi, Behrooz; Rahmati, Farhad; Forouzanfar, Mohammad Mehdi; Motamedi, Maryam; Mirmohseni, Ladan2016-01-01Background: Determining etiologic causes and prognosis can significantly improve management of syncope patients. The present study aimed to compare the values of San Francisco, Osservatorio Epidemiologico sulla Sincope nel Lazio (OESIL), Boston, and Risk Stratification of Syncope in the Emergency Department (ROSE) score clinical decision rules in predicting the short-term serious outcome of syncope patients.

Materials and Methods: The present diagnostic accuracy study with 1-week follow-up was designed to evaluate the predictive values of the four mentioned clinical decision rules. Screening performance characteristics of each model in predicting mortality, myocardial infarction (MI), and cerebrovascular accidents (CVAs) were calculated and compared. To evaluate the value of each aforementioned model in predicting the outcome, sensitivity, specificity, positive likelihood ratio, and negative likelihood ratio were calculated and receiver-operating curve (ROC) curve analysis was done. Results: A total of 187 patients (mean age: 64.2 ± 17.2 years) were enrolled in the study. Mortality, MI, and CVA were seen in 19 (10.2%), 12 (6.4%), and 36 (19.2%) patients, respectively.

Area under the ROC curve for OESIL, San Francisco, Boston, and ROSE models in prediction the risk of 1-week mortality, MI, and CVA was in the 30–70% range, with no significant difference among models (P 0.05). The pooled model did not show higher accuracy in prediction of mortality, MI, and CVA compared to others (P 0.05). Conclusion: This study revealed the weakness of all four evaluated models in predicting short-term serious outcome of syncope patients referred to the emergency department without any significant advantage for one among others. PMID:27904602.Safari, Saeed; Baratloo, Alireza; Hashemi, Behrooz; Rahmati, Farhad; Forouzanfar, Mohammad Mehdi; Motamedi, Maryam; Mirmohseni, Ladan2016-01-01Determining etiologic causes and prognosis can significantly improve management of syncope patients. The present study aimed to compare the values of San Francisco, Osservatorio Epidemiologico sulla Sincope nel Lazio (OESIL), Boston, and Risk Stratification of Syncope in the Emergency Department (ROSE) score clinical decision rules in predicting the short-term serious outcome of syncope patients. The present diagnostic accuracy study with 1-week follow-up was designed to evaluate the predictive values of the four mentioned clinical decision rules. Screening performance characteristics of each model in predicting mortality, myocardial infarction (MI), and cerebrovascular accidents (CVAs) were calculated and compared.

Sano Motoharu No Damage Raritan County

To evaluate the value of each aforementioned model in predicting the outcome, sensitivity, specificity, positive likelihood ratio, and negative likelihood ratio were calculated and receiver-operating curve (ROC) curve analysis was done. A total of 187 patients (mean age: 64.2 ± 17.2 years) were enrolled in the study. Mortality, MI, and CVA were seen in 19 (10.2%), 12 (6.4%), and 36 (19.2%) patients, respectively. Area under the ROC curve for OESIL, San Francisco, Boston, and ROSE models in prediction the risk of 1-week mortality, MI, and CVA was in the 30-70% range, with no significant difference among models ( P 0.05).

The pooled model did not show higher accuracy in prediction of mortality, MI, and CVA compared to others ( P 0.05). This study revealed the weakness of all four evaluated models in predicting short-term serious outcome of syncope patients referred to the emergency department without any significant advantage for one among others.Yamashita, Shimpei; Kohjimoto, Yasuo; Iguchi, Takashi; Koike, Hiroyuki; Kusumoto, Hiroki; Iba, Akinori; Kikkawa, Kazuro; Kodama, Yoshiki; Matsumura, Nagahide; Hara, Isao2016-03-22While novel drugs have been developed, docetaxel remains one of the standard initial systemic therapies for castration-resistant prostate cancer (CRPC) patients. Despite the excellent anti-tumor effect of docetaxel, its severe adverse effects sometimes distress patients. Therefore, it would be very helpful to predict the efficacy of docetaxel before treatment. The aims of this study were to evaluate the potential value of patient characteristics in predicting overall survival (OS) and to develop a risk classification for CRPC patients treated with docetaxel-based chemotherapy.

This study included 79 patients with CRPC treated with docetaxel. The variables, including patient characteristics at diagnosis and at the start of chemotherapy, were retrospectively collected. Prognostic factors predicting OS were analyzed using the Cox proportional hazard model. Risk stratification for overall survival was determined based on the results of multivariate analysis. PSA response ≥50% was observed in 55 (69.6%) of all patients, and the median OS was 22.5 months. The multivariate analysis showed that age, serum PSA level at the start of chemotherapy, and Hb were independent prognostic factors for OS. In addition, ECOG performance status (PS) and the CRP-to-albumin ratio were not significant but were considered possible predictors for OS.

Sano motoharu no damage raritan township

Risk stratification according to the number of these risk factors could effectively stratify CRPC patients treated with docetaxel in terms of OS. Age, serum PSA level at the start of chemotherapy, and Hb were identified as independent prognostic factors of OS. ECOG PS and the CRP-to-albumin ratio were not significant, but were considered possible predictors for OS in Japanese CRPC patients treated with docetaxel. Risk stratification based on these factors could be helpful for estimating overall survival.Scott, A J; Mason, S E; Arunakirinathan, M; Reissis, Y; Kinross, J M; Smith, J J2015-04-01Current management of suspected appendicitis is hampered by the overadmission of patients with non-specific abdominal pain and a significant negative exploration rate. The potential benefits of risk stratification by the Appendicitis Inflammatory Response (AIR) score to guide clinical decision-making were assessed. During this 50-week prospective observational study at one institution, the AIR score was calculated for all patients admitted with suspected appendicitis. Appendicitis was diagnosed by histological examination, and patients were classified as having non-appendicitis pain if histological findings were negative or surgery was not performed.

The diagnostic performance of the AIR score and the potential for risk stratification to reduce admissions, optimize imaging and prevent unnecessary explorations were quantified. A total of 464 patients were included, of whom 210 (633 per cent) with non-appendicitis pain were correctly classified as low risk. However, 13 low- risk patients had appendicitis. Low- risk patients accounted for 481 per cent of admissions (223 of 464), 57 per cent of negative explorations (48 of 84) and 507 per cent of imaging requests (149 of 294). An AIR score of 5 or more (intermediate and high risk) had high sensitivity for all severities of appendicitis (90 per cent) and also for advanced appendicitis (98 per cent). An AIR score of 9 or more (high risk) was very specific (97 per cent) for appendicitis, and the majority of patients with appendicitis in the high- risk group (21 of 30, 70 per cent) had perforation or gangrene. Ultrasound imaging could not exclude appendicitis in low- risk patients (negative likelihood ratio (LR) 10) but could rule-in the diagnosis in intermediate- risk patients (positive LR 102).

Sano Motoharu No Damage Raritan Township

CT could exclude appendicitis in low- risk patients (negative LR 00) and rule-in appendicitis in the intermediate group (positive LR 109). Risk stratification of patients with suspected appendicitis by the AIR score could.Taj, M; Nadeem, M; Maqsood, S; Shah, T; Farzana, T; Shamsi, T S2017-09-01The purpose of this study is to evaluate the association of MASCC score (Multinational Association for Supportive Care in Cancer Score) in patients with febrile neutropenia (as resultant treatment of hematological disorders) for risk assessment of morbidity and mortality. Patients presenting with Febrile Neutropenia from November 2011 till December 2013 were enrolled in the study. Initially all patients were hospitalized and their MASCC score was calculated, however those with high risk stayed in hospital till full ANC recovery while low risk group was discharged earlier and keenly followed as out- patient while being on prophylactic oral antibiotics. The MASCC risk-index score was calculated and patients with risk score 21 were regarded as low- risk while 5 years. Methods Tumor cytogenetics were systematically investigated by interphase fluorescence in situ hybridization in 302 meningioma samples, and the proposed classification was further validated in an independent series of cases (n = 132) analyzed by high-density (500K) single-nucleotide polymorphism (SNP) arrays. Results Overall, we found an adverse impact on patient relapse-free survival (RFS) for males, presence of brain edema, younger patients (50 mm, tumor localization at intraventricular and anterior cranial base areas, WHO grade II/III meningiomas, and complex karyotypes; the latter 5 variables showed an independent predictive value in multivariate analysis.

Arkaos grandvj 1.2.2. Based on these parameters, a prognostic score was established for each individual case, and patients were stratified into 4 risk categories with significantly different (P.

Watch now the video Motoharu Sano - No Damage:.佐野元春 スターダスト・キッズ (ライブムービー) 出来れば、ヘッドホンでお聴き下さい。(Please listen with headphones if possible.).佐野元春 ガラスのジェネレーション(ライブムービー) 出来れば、ヘッドホンでお聴き下さい。(Please listen with headphones if possible.).佐野元春 - SOMEDAY - Motoharu Sano 大好きな佐野元春の「SOMEDAY」です。 感動します。.モリスンは朝、空港で/佐野元春 (cover).It s alright 佐野元春カバー.▶ ハッピーマン Happy Man 佐野元春 Motoharu Sano (.Uke Cover 佐野元春の「ハッピーマン」をウクレレ弾き語りでカバーしてみました。パーカッションは右足にセットして一発録り。 Ukulele: Flea (Soprano) Percussio.16 - グッドバイからはじめよう/佐野元春 - cover The WHB's Live at club FLEEZ 1st. 20140816.アンジェリーナ (LIVE) 佐野元春 & THE COYOTE BAND 佐野元春の原点、永遠のロックンロール・クラシック。 LIVE AT TOKYO DOME CITY HALL 2018年4月1日 FROM THE ALBUM `BACK TO THE STREET` (1980).So Young(佐野元春カバー) 信長正義 作詞/作曲 佐野元春 So Young(佐野元春カバー) 信長正義 作詞/作曲 佐野元春 新橋ZZ 2012年6月6日.佐野元春 (Someday) ”SUGARTIME” ”HAPPY MAN” ”DOWN TOWN BOY” ”BELIEVE IN YOU” ”SOMDAY” ハイレゾ化 始めたかったアルバムです。.彼女はデリケート (カラオケ) 佐野元春.さのもとはる「こんなすてきなひには」.情けない週末 - Weekend 佐野元春「情けない週末」を一人で演奏してみた。 I played Motoharu Sano's 'Weekend' by myself.▶ Bye Bye Handy Love 佐野元春 Motoharu Sano - Uke cover ウスレレ「IZ」を使った最初の弾き語りビデオです。IZの音色がR&Rやポピュラーソング向きなのでどんどんイマジネーションが湧いてきます。佐野.

Posted :